Protein and macronutrient blends are expected to dominate with a 43% share in 2025
Del Prato S, Kahn SE, Pavo I, et al
Both medical weight loss and low-carb nutrition are proven strategies, but together they create a powerful synergy: GLP-1 Medications Control Appetite and Cravings Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work by: Reducing hunger and increasing satiety Slowing gastric emptying so you feel full longer Decreasing cravings, especially for high-carbohydrate foods Improving insulin sensitivity Supporting sustainable calorie reduction without constant hunger Low-Carb Nutrition Optimizes Metabolic Health Low-carbohydrate eating provides complementary benefits: Stabilizes blood sugar levels, preventing energy crashes and cravings Reduces insulin levels, promoting fat burning over fat storage Decreases inflammation throughout the body Improves lipid profiles (cholesterol and triglycerides) Provides sustained energy without the blood sugar roller coaster Naturally reduces calorie intake while maintaining satiety Together, They Create Synergy When you combine GLP-1 medications with low-carb nutrition: Enhanced appetite control: The medication reduces hunger while low-carb foods provide sustained satiety Stabilized blood sugar: Both strategies improve insulin sensitivity and glucose control Accelerated fat loss: Lower insulin levels from carb reduction promote fat burning, while medication supports calorie reduction Reduced cravings: GLP-1 medications dampen carb cravings, making low-carb eating easier to sustain Improved metabolic markers: Combined improvements in diabetes, blood pressure, and cholesterol markers Better energy: Stable blood sugar provides consistent energy throughout the day The Blissful Wellness Integrated Approach Medical Supervision by Board-Certified Physicians Your journey is overseen by Dr
An open-label RCT in n = 44 patients with obesity and subclinical binge-eating found a greater reduction in binge-eating at 12 weeks in liraglutide versus control (diet and exercise) groups [20]
Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects
Document Data Record all cold chain packaging use, results and temperature logs
